Back to Search
DU PONT GUERRY, MD
MD
Hematology (Internal Medicine) Physician
NPI: 1902849292Individual
Specialties, Licenses & Credentials
Hematology (Internal Medicine) PhysicianPrimary
Internal Medicine — Hematology
Code: 207RH0000X
MD016232E(PA)
Research & Publications (20)
Therapeutic effect of sentinel lymph node biopsy in melanoma remains an open question.
PMID 19667261·J Clin Oncol·2009
8-other
Lymphatic invasion revealed by multispectral imaging is common in primary melanomas and associates with prognosis.
PMID 18440591·Hum Pathol·2008
8-other
Using benchmarks based on historical survival rates for screening new therapies for stage IV melanoma patients.
PMID 18235111·J Clin Oncol·2008
8-other
Shared MHC class II-dependent melanoma ribosomal protein L8 identified by phage display.
PMID 17440064·Cancer Res·2007
7-preclinical
Identification of high-risk patients among those diagnosed with thin cutaneous melanomas.
PMID 17369575·J Clin Oncol·2007
4-observational
Regional nodal metastatic disease is the strongest predictor of survival in patients with thin vertical growth phase melanomas: a case for SLN Staging biopsy in these patients.
PMID 17285396·Ann Surg Oncol·2007
8-other
Reproductive risk factors for cutaneous melanoma in women: a case-control study.
PMID 17158470·Am J Epidemiol·2007
8-other
Predicting sentinel node status in AJCC stage I/II primary cutaneous melanoma.
PMID 17058288·Cancer·2006
8-other
Differentiation of normal skin and melanoma using high resolution hyperspectral imaging.
PMID 16931902·Cancer Biol Ther·2006
8-other
Identifying individuals at high risk of melanoma: a practical predictor of absolute risk.
PMID 16728488·J Clin Oncol·2006
8-other
Human leukocyte antigen-A2-restricted CTL responses to mutated BRAF peptides in melanoma patients.
PMID 16540682·Cancer Res·2006
8-other
Predictors of regional nodal disease in patients with thin melanomas.
PMID 16523360·Ann Surg Oncol·2006
8-other
Migration of cytotoxic T lymphocytes toward melanoma cells in three-dimensional organotypic culture is dependent on CCL2 and CCR4.
PMID 16421945·Eur J Immunol·2006
7-preclinical
CD8+, HLA-unrestricted, cytotoxic T-lymphocyte line against malignant melanoma.
PMID 16281981·J Transl Med·2005
8-other
A population-based validation of the American Joint Committee on Cancer melanoma staging system.
PMID 16258105·J Clin Oncol·2005
4-observational
Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
PMID 16258103·J Clin Oncol·2005
4-observational
Mitotic rate as a predictor of sentinel lymph node positivity in patients with thin melanomas.
PMID 15864482·Ann Surg Oncol·2005
8-other
CXC chemokine ligand 12 (stromal cell-derived factor 1 alpha) and CXCR4-dependent migration of CTLs toward melanoma cells in organotypic culture.
PMID 15843590·J Immunol·2005
8-other
Heterogeneity of risk for melanoma and pancreatic and digestive malignancies: a melanoma case-control study.
PMID 15529312·Cancer·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3400 SPRUCE ST, 15 PENN TOWER
PHILADELPHIA, PA 19104 - Phone
- (215) 662-3914
Quick Facts
- NPI
- 1902849292
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile